Clareo Health | Phase I Study Evaluating the Treatment of Patients With Locally Advanced Pancreatic Cancer With Carbon Ion Radiotherapy: The PHOENIX-01 Trial
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University Hospital Heidelberg
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients meeting all of the following criteria will be considered for admission to the trial:
histologically confirmed locally advanced pancreatic cancer or imaging defined pancreatic cancer combined with elevated CA-19-9
macroscopic tumor after biopsy
age ≥ 18 years of age
Karnofsky Performance Score \>=60
For women with childbearing potential, (and men) adequate contraception (sexual abstinence, estrogen- or gestagen containing contraceptive medication etc.)
Female participants: No pregnancy present (pregnancy test required)
Ability of subject to understand character and individual consequences of the clinical trial
Written informed consent (must be available before enrolment in the trial)
You may not be if
Patients presenting with any of the following criteria will not be included in the trial:
distant metastases
refusal of the patients to take part in the study
previous radiotherapy of the abdomen
Patients who have not yet recovered from acute toxicities of prior therapies
Known carcinoma \< 5 years ago (excluding Carcinoma in situ of the cervix, basal cell carcinoma, squamous cell carcinoma of the skin) requiring immediate treatment interfering with study therapy
Pregnant or lactating women
Participation in another clinical study or observation period of competing trials, respectively
